TIAA CREF INVESTMENT MANAGEMENT LLC - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 2.16 and the average weighting 0.4%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$6,339,000
-15.2%
509,592
-6.7%
0.01%0.0%
Q3 2016$7,479,000
+75.5%
546,300
-5.3%
0.01%
+66.7%
Q2 2016$4,262,000
+19.1%
576,678
+3.0%
0.00%0.0%
Q1 2016$3,579,000
-13.3%
560,139
-15.2%
0.00%0.0%
Q4 2015$4,128,000
-5.2%
660,509
-11.4%
0.00%0.0%
Q3 2015$4,354,000
-35.7%
745,633
-8.9%
0.00%
-40.0%
Q2 2015$6,770,000
+1.9%
818,604
+1.5%
0.01%0.0%
Q1 2015$6,646,000
+20.3%
806,573
+0.3%
0.01%
+25.0%
Q4 2014$5,526,000
+21.2%
804,399
-4.7%
0.00%
+33.3%
Q3 2014$4,559,000
-17.9%
844,321
-3.2%
0.00%
-25.0%
Q2 2014$5,553,000
+141.5%
871,817
+205.6%
0.00%
+100.0%
Q1 2014$2,299,000
+1170.2%
285,269
+976.5%
0.00%
Q4 2013$181,000
-99.1%
26,499
-97.4%
0.00%
-100.0%
Q3 2013$19,093,000
-17.3%
1,037,689
-21.4%
0.02%
-21.1%
Q2 2013$23,077,0001,319,4350.02%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$69,390,00026.80%
Opaleye Management Inc. 1,500,000$8,100,000,0006.31%
Camber Capital Management LP 6,000,000$32,400,0003.04%
Ghost Tree Capital, LLC 700,000$3,780,0002.05%
Granite Point Capital Management, L.P. 700,000$3,780,0001.88%
Duquesne Family Office 1,645,000$8,883,0001.09%
Geduld E E 272,200$1,470,0001.04%
Elk Creek Partners, LLC 659,232$3,560,0000.93%
Palo Alto Investors LP 2,231,717$12,051,0000.90%
HighVista Strategies LLC 1,200,000$6,480,0000.87%
View complete list of ARIAD PHARMACEUTICALS INC shareholders